drugset / Trial / NCT04026568

A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma

NCT04026568

Phase 2/3 Terminated 1 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study is to evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. The investigational treatment will be used to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.

Timeline

Start
2021-08-17
Primary completion
2022-07-18
Completion
2022-07-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalfampridine Small molecule 10 mg Oral

Indications